177 related articles for article (PubMed ID: 21875477)
1. [State of art of the radiofrequency ablation of colorectal liver metastases].
Zhao M; Wang JP; Wu PH
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):401-4. PubMed ID: 21875477
[No Abstract] [Full Text] [Related]
2. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
[TBL] [Abstract][Full Text] [Related]
3. [Radiofrequency ablation in the multimodal treatment of liver metastases--preliminary report].
Burcoveanu C; Dogaru C; Diaconu C; Grecu F; Dragomir C; Pricop A; Balan G; Drug VL
Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):423-7. PubMed ID: 17983178
[TBL] [Abstract][Full Text] [Related]
4. The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.
Scartozzi M; Siquini W; Galizia E; Stortoni P; Marmorale C; Berardi R; Fianchini A; Cascinu S
Dig Liver Dis; 2011 Mar; 43(3):194-8. PubMed ID: 20728416
[TBL] [Abstract][Full Text] [Related]
5. Perioperative chemotherapy for resectable hepatic metastases.
Kopetz S; Vauthey JN
Lancet; 2008 Mar; 371(9617):963-5. PubMed ID: 18358910
[No Abstract] [Full Text] [Related]
6. Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version.
Zalinski S; Mariette C; Farges O; ; ;
J Visc Surg; 2011 Jun; 148(3):e171-82. PubMed ID: 21703959
[No Abstract] [Full Text] [Related]
7. [Multiple liver metastases due to sigmoid colon cancer successfully treated by degradable starch microspheres (DSM)-TAE, radiofrequency ablation therapy, and Uzel/UFT].
Ishikawa T; Higuchi K; Kubota T; Seki K; Ohta H; Yoshida T; Kamimura T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):335-8. PubMed ID: 20154497
[TBL] [Abstract][Full Text] [Related]
8. Role of local liver therapy for hepatic metastases from colorectal cancer.
Kemeny N
Clin Adv Hematol Oncol; 2009 Dec; 7(12):815-7. PubMed ID: 20332753
[No Abstract] [Full Text] [Related]
9. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
11. [Recurrance of disappearing colorectal liver metastases after mFOLFOX6 regimen].
Ono T; Okada N; Kumamoto K; Ishibashi K; Haga N; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2214-5. PubMed ID: 22202334
[TBL] [Abstract][Full Text] [Related]
12. What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?
O'Neil BH; Goldberg RM
Nat Clin Pract Oncol; 2009 Jan; 6(1):14-6. PubMed ID: 19002130
[No Abstract] [Full Text] [Related]
13. [Results of neo-adjuvant chemotherapy by FOLFOX and FOLFIRI for colorectal liver metastasis].
Amano R; Yamada N; Noda E; Kubo N; Tanaka H; Muguruma K; Inoue T; Yashiro M; Maeda K; Onoda N; Sawada T; Nakata B; Ohira M; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2003-5. PubMed ID: 20037305
[TBL] [Abstract][Full Text] [Related]
14. Improved first-line chemotherapy: a better chance for surgery?
Tejpar S; Van Cutsem E; Adam R
Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480
[No Abstract] [Full Text] [Related]
15. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.
Neumann UP; Thelen A; Röcken C; Seehofer D; Bahra M; Riess H; Jonas S; Schmeding M; Pratschke J; Bova R; Neuhaus P
Surgery; 2009 Jul; 146(1):52-9. PubMed ID: 19541010
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment of hepatic metastases of colorectal neoplasms].
Landi E
G Chir; 2004 Oct; 25(10):317-23. PubMed ID: 15756953
[No Abstract] [Full Text] [Related]
17. A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone as treatment for liver metastasis from colorectal cancer: Japan Clinical Oncology Group Study JCOG0603.
Kanemitsu Y; Kato T; Shimizu Y; Inaba Y; Shimada Y; Nakamura K; Sato A; Moriya Y;
Jpn J Clin Oncol; 2009 Jun; 39(6):406-9. PubMed ID: 19389795
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.
Power DG; Kemeny NE
Crit Rev Oncol Hematol; 2011 Sep; 79(3):251-64. PubMed ID: 20970353
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
[TBL] [Abstract][Full Text] [Related]
20. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
